Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil and finasteride are FDA-approved treatments for male hair loss, but off-label use of oral minoxidil, dutasteride, and higher doses of finasteride and minoxidil is increasing.

PRP can help treat hair loss but needs standardized methods for best results.

Many people with hair loss had low iron and ferritin levels.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

People with more than 11 skin tags, especially on the thigh, neck, or armpit, may have a higher chance of metabolic syndrome.

Ganoderma lucidum powder may help prevent skin cancer and lower cholesterol.

Invasive treatments can improve hair growth, but effectiveness varies and more research is needed.

Green tea may help relieve PCOS symptoms, but more research is needed.

Myoinositol effectively manages PCOS with fewer side effects than metformin.

Laser therapy shows promise for hair loss but lacks strong evidence due to limited studies.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Photobiomodulation effectively improves skin and hair conditions with minimal side effects.

Store Tectona grandis leaf extracts in slightly acidic, light-protected conditions for best stability.

WS Biotin, a new form of D-Biotin, improves water solubility and shows potential for hair and skin care without being toxic at low levels.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

Minoxidil, finasteride, and PRP are the most effective and accessible treatments for male pattern hair loss.

PCOS is a complex condition that affects women's hormonal balance and metabolism, requiring lifestyle changes and medical management.

Scalp cryotherapy significantly reduces hair loss during and shortly after chemotherapy.

Certain ESR1 gene variations may affect hormone levels and fat distribution in women with high male hormone levels.

A woman's severe male hormone excess was caused by a small, hard-to-find ovarian tumor.

A 13-year-old boy with Cushing syndrome has high cortisol levels from a pituitary gland issue and underdeveloped sexual characteristics.

Treating prolactinoma doesn't significantly affect hirsutism or cause high androgen levels.

Lichen planus is not linked to metabolic syndrome, but it is associated with higher rates of high blood pressure, high triglycerides, and low HDL cholesterol.

PRGF is a promising treatment for hair loss with some patient benefits.

Men with male pattern baldness may have a higher risk of heart disease due to increased levels of a specific lipid in their blood.

Hair can show daily calcium changes, linked to body calcium levels and influenced by hormones, and can help assess calcium metabolism issues.

The conclusion is that there's a link between high testosterone levels, insulin resistance, and certain skin conditions, regardless of obesity.

Androgen-producing ovarian tumors can cause male-pattern hair loss in women.

Early balding in men is linked to metabolic syndrome, so screening is important for prevention.

Dupilumab may help treat alopecia areata without needing high IgE levels.